Navigation Links
Raven biotechnologies Announces Collaboration With Monogram Biosciences to Advance Diagnostic Cancer Technologies
Date:4/8/2008

SOUTH SAN FRANCISCO, Calif., April 8, 2008 /PRNewswire/ -- Raven biotechnologies, inc., a privately held company focused on the discovery and development of monoclonal antibody therapeutics (MAbs) for cancer announced today that it has entered into an agreement with Monogram Biosciences, Inc., under which Monogram will evaluate selected Raven monoclonal antibodies for use with its VeraTag(TM) technology for diagnosis of cancer.

"Raven's extensive library of antibody candidates that bind to antigens present at high levels on tumor tissue can be developed as therapeutic and diagnostic antibodies," stated George Schreiner, M.D., Ph.D., chief executive officer of Raven biotechnologies. "Through our collaboration with Monogram we hope ultimately to accelerate the development of targeted oncology therapeutics."

The Raven technology platform has generated well-characterized, high-affinity monoclonal antibodies to proteins on the cell surface that can be used to quickly identify and validate targets. The platform has delivered an extensive library of antibodies targeting novel and recognized antigens. Raven is initially focusing on antibody-based therapeutics targeting lung, colon, pancreatic, prostate, breast, and ovarian cancer.

Monogram Biosciences' VeraTag(TM) technology can accelerate the development of targeted therapeutics, improve clinical trial design and results, clarify and individualize the selection of medications, and optimize outcomes for patients with cancer and other serious diseases.

About Raven biotechnologies

Raven biotechnologies, inc. (http://www.ravenbio.com) is a privately held biotechnology company focused on the development of monoclonal antibody therapeutics for treating cancer. Raven's lead product candidate, RAV12, targets adenocarcinomas and is in clinical development for the treatment of gastrointestinal and other cancers. Raven's discovery process si
'/>"/>

SOURCE Raven biotechnologies, inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Positive Outcome of Drug-Drug Interaction Trial With Intravenous Iclaprim
2. Raven biotechnologies, inc. and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies
3. First Patients Enrolled in Phase II Trial With Intravenous Iclaprim in HAP/VAP/HCAP
4. Lentigen Appoints Tim Ravenscroft as Chief Executive Officer
5. VaxGen and Raven Announce Form S4 Registration Statement Declared Effective
6. Raven biotechnologies to Provide Updates on Oncology Pipeline With Four AACR Presentations
7. Arpida Provides Update on Progress of New Drug Application for Intravenous Iclaprim
8. Raven Announces RAV12 Phase 1/2a Study Results To Be Presented at ASCO
9. Arpida Submits New Drug Application for Intravenous Iclaprim for Treatment of Skin Infections
10. VaxGen and Raven Terminate Merger Agreement
11. Raven biotechnologies and Bioprocessing Technology Institute Announce Collaboration to Advance Discovery of Stem Cell Antibodies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Health care employment grew by... only one to show consistent growth during the U.S...als remain in trouble, and health systems are comi...nel, instead of just administrators. , ...care employment continued growing in October despi...
(Date:11/24/2009)... , SAN MATEO, Calif., Nov. 24 /PRNewswire-Fir...pharmaceutical company focused on developing and c...nounced today that Anthony DiTonno, President and ...t the 21st Annual Piper Jaffray Health Care Confer...k Palace Hotel in New York, New York. ,, Mr. D...
(Date:11/24/2009)... The FBI recently approved the Pr...es participating in or generating DNA records for ... Madison, WI USA (PRWEB) -- The FBI recentl...m for use by laboratories participating in, or ge...ystem (NDIS). NDIS currently contains more than se...
(Date:11/24/2009)..., DUBLIN, November 24 /PRNewswire-FirstCall...obal specialty biopharmaceutical company, today,an...n Medicines Agency for,velaglucerase alfa, the com...or the treatment of Type 1 Gaucher disease. This i...e alfa that has been submitted, with previous,subm...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4
...gher gDNA Concentrations with the Perfect gDNA Blo...on Volume , , , , , , , ... Eppendorf 5 Prime, Boulder, Colorado, , ,...The Eppendorf Perfect gDNA Blood Mini Kit protoc...l for maximum total yield in standard , a...
..., , , , , , , , ... yields of 1520 , g lgt10 DNA per 450 l of ... be used in conjunction with other LambdaDNA purif... Grow a 10 ml stock of suitable plating bacteri...0.5% yeast extract, 0.5% NaCl, 1 mM MgSO4, pH 7.5)...
... , , , , , , Katherine...atherine A. Borkovich PhD, University of Texas-Hou...icrobiology and Molecular Genetics, Houston, Texas...ruments Inc., BioSystems Application , Lab,... , INTRODUCTION: , The diverse rep...
Other Biology Technology:Higher gDNA Concentrations with the Perfect gDNA Blood Mini Kit , by Varying the Final Elution Volume 2Higher gDNA Concentrations with the Perfect gDNA Blood Mini Kit , by Varying the Final Elution Volume 3Higher gDNA Concentrations with the Perfect gDNA Blood Mini Kit , by Varying the Final Elution Volume 4Higher gDNA Concentrations with the Perfect gDNA Blood Mini Kit , by Varying the Final Elution Volume 5Higher gDNA Concentrations with the Perfect gDNA Blood Mini Kit , by Varying the Final Elution Volume 6Higher gDNA Concentrations with the Perfect gDNA Blood Mini Kit , by Varying the Final Elution Volume 7Lambda DNA Extraction Protocol 2Efficient Transfection of Neurospora Crassa 2Efficient Transfection of Neurospora Crassa 3Efficient Transfection of Neurospora Crassa 4Efficient Transfection of Neurospora Crassa 5
(Date:11/25/2009)...NA, Calif.Scientists at the California Institute o...a primitive emotion-like behavior in the fruit fly...hich may be relevant to the relationship between t... hyperactivity disorder (ADHD), are described in t... Drosophila brain contains only about 20,000 neu...
(Date:11/25/2009)...tember 11, firefighters, police officers and ambul...he World Trade Center complex. They battled to sav... for survivors, tackled fires and evacuated as man...an estimated 17,000 people. And making their jobs ...: frightened workers and their relatives jammed mo...
(Date:11/25/2009)...he course of a lifetime, the heart pumps some 250 ...rder to do this, the muscle fibers of the heart ha...ded by Dr. Wolfgang Rottbauer, vice chair of the D... Hospital (Chairman: Prof. Dr. H. A. Katus), has d...ability of the smallest muscular unit, the sarcome...
Breaking Biology News(10 mins):Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4Magic box for mission impossible 2Magic box for mission impossible 3New genetic cause of cardiac failure discovered 2Wolters Kluwer Health Appoints Anne Woods to Chief Nursing Officer 3B Strengthens Its Commitment to the Nursing Market 60802 1Wolters Kluwer Health Appoints Anne Woods to Chief Nursing Officer 3B Strengthens Its Commitment to the Nursing Market 60802 2Wolters Kluwer Health Appoints Anne Woods to Chief Nursing Officer 3B Strengthens Its Commitment to the Nursing Market 60802 3AVMA Updates H1N1 Flu Resources for Pet Owners Veterinarians 60797 1Helix BioPharma Corp Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha 2b in Patients With Ano Genital Warts 6036 1Helix BioPharma Corp Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha 2b in Patients With Ano Genital Warts 6036 2Helix BioPharma Corp Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha 2b in Patients With Ano Genital Warts 6036 3Helix BioPharma Corp Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha 2b in Patients With Ano Genital Warts 6036 4Helix BioPharma Corp Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha 2b in Patients With Ano Genital Warts 6036 5Helix BioPharma Corp Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha 2b in Patients With Ano Genital Warts 6036 6
...first large, single-institution series directly co...ts, researchers from the University of Chicago fou...oduced substantially better weight-loss outcomes t...bypass. , In the October issue of the Annals of S...witch (DS) produced greater weight loss than the R...
...nt years, health professionals and the general pub... ravages that could result from a flu pandemic. Al...s of 1968 and 1957, it is the infamous 1918-1920 p...at scale--that causes the most trepidation. , S... many people died from this particular strain of t...
...hers have discovered that even a small amount of M...e brain, according to the first study to look at t...onal drug in new ecstasy users. The findings were ...logical Society of North America (RSNA). , “We fou...f the brain in young adults who just started to us...
Other Biology News:For super-obese patients, duodenal switch beats gastric bypass 2For super-obese patients, duodenal switch beats gastric bypass 3Recurrence of a flu pandemic similar to infamous 1918 flu could kill 62 million 2Recurrence of a flu pandemic similar to infamous 1918 flu could kill 62 million 3Ecstasy can harm the brains of first-time users 2
Cytidine 5-Triphosphate, Sodium (CTP) from GE Healthcare, formerly Amersham Biosciences
... Blotting Reagent Pack, 1. Contains reagents for ...ane-bound mouse and rabbit primary antibodies. Des...s. Detection reagents are not included, but the sy...: Blotting & Labeling & Detection, Protein Labelin...
...LVF-UV-HL, LVF-CUV-ADP, FHS-LVF and CVD-Diffuse W...Linear Variable Filters to create the world's firs...h and adjustable bandpass. Each filter features an...and (99.8%). These filters -- with interference c...
Silencer Validated siRNA 5 nmol from Ambion
Biology Products: